Wednesday, May, 22, 2019 01:24:11

Cantel Medical Corp. to enter Europe market, acquires Omnia S.p.A

Cantel Medical Corporation, a U.S.-based medical equipment company, has reportedly announced that it intends to acquire Omnia S.p.A, a renowned Italian dental surgical consumables provider. With the acquisition, Cantel Medical Corp. aims to further foray into the European market – which Omnia is a leading …

BlackRidge Technology & ImagineMed to enhance patient data security

Next-gen cyber solutions provider, BlackRidge Technology International has reportedly partnered with leading healthcare technology provider ImagineMed, to protect patient data and ImagineMed’s delivery model. As per trusted sources, the partnership will enable BlackRidge to develop a software-defined security perimeter that safeguards patient data when at …

United Therapeutics invests $800M upfront in Arena’s PAH drug

U.S. biotechnology firm, United Therapeutics Corp. has recently invested $800 million cash upfront to grab rights to Arena Pharmaceuticals’ pulmonary arterial hypertension (PAH) drug, Ralinepag. As per sources, the firm’s executive crew believes that the acquired rights would enable the company to gain huge revenues …

India and the UK ink MoU to conjointly work on cancer research

The Ministry of Science and Technology has recently announced that India and the United Kingdom have both signed a Memorandum of Understanding (MoU) for collaborating on cancer research at the Inaugural Researchers’ Conference in New Delhi. The India-UK Cancer Research Initiative focused on developing affordable …

IMV joins Merck to gauge DPX-Survivac, declares Phase 2 basket trial

IMV Incorporation, a clinical stage biopharmaceutical company, has reportedly declared the expansion of its clinical program through a Phase 2 basket trial assessing its prime drug, DPX-Survivac, combined with KEYTRUDA (pembrolizumab) and cyclophosphamide, in patients suffering from recurrent or advanced solid tumors. Frederic Ors, Chief …